HEADER TRANSCRIPTION/INHIBITOR 03-MAY-17 5VOM TITLE BENZOPIPERAZINE BET BROMODOMAIN INHIBITOR IN COMPLEX WITH BD1 OF BRD4 COMPND MOL_ID: 1; COMPND 2 MOLECULE: BROMODOMAIN-CONTAINING PROTEIN 4; COMPND 3 CHAIN: A, B; COMPND 4 SYNONYM: PROTEIN HUNK1; COMPND 5 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: BRD4, HUNK1; SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 511693; SOURCE 8 EXPRESSION_SYSTEM_STRAIN: BL21-CODONPLUS KEYWDS BROMODOMAIN BRD4 BET BENZOPIPERAZINE, TRANSCRIPTION-INHIBITOR COMPLEX EXPDTA X-RAY DIFFRACTION AUTHOR A.V.TOMS,T.HERBERTZ REVDAT 3 13-MAR-24 5VOM 1 REMARK REVDAT 2 06-SEP-17 5VOM 1 JRNL REVDAT 1 02-AUG-17 5VOM 0 JRNL AUTH D.S.MILLAN,K.J.KAYSER-BRICKER,M.W.MARTIN,A.C.TALBOT, JRNL AUTH 2 S.E.R.SCHILLER,T.HERBERTZ,G.L.WILLIAMS,G.P.LUKE,S.HUBBS, JRNL AUTH 3 M.A.ALVAREZ MORALES,D.CARDILLO,P.TROCCOLO,R.L.MENDES, JRNL AUTH 4 C.MCKINNON JRNL TITL DESIGN AND OPTIMIZATION OF BENZOPIPERAZINES AS POTENT JRNL TITL 2 INHIBITORS OF BET BROMODOMAINS. JRNL REF ACS MED CHEM LETT V. 8 847 2017 JRNL REFN ISSN 1948-5875 JRNL PMID 28835800 JRNL DOI 10.1021/ACSMEDCHEMLETT.7B00191 REMARK 2 REMARK 2 RESOLUTION. 1.67 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : REFMAC 5.7.0029 REMARK 3 AUTHORS : MURSHUDOV,SKUBAK,LEBEDEV,PANNU,STEINER, REMARK 3 : NICHOLLS,WINN,LONG,VAGIN REMARK 3 REMARK 3 REFINEMENT TARGET : NULL REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 1.67 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 39.18 REMARK 3 DATA CUTOFF (SIGMA(F)) : NULL REMARK 3 COMPLETENESS FOR RANGE (%) : 96.4 REMARK 3 NUMBER OF REFLECTIONS : 26420 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING + TEST SET) : 0.177 REMARK 3 R VALUE (WORKING SET) : 0.175 REMARK 3 FREE R VALUE : 0.218 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.100 REMARK 3 FREE R VALUE TEST SET COUNT : 1412 REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 20 REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 1.67 REMARK 3 BIN RESOLUTION RANGE LOW (A) : 1.71 REMARK 3 REFLECTION IN BIN (WORKING SET) : 1784 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 87.82 REMARK 3 BIN R VALUE (WORKING SET) : 0.2390 REMARK 3 BIN FREE R VALUE SET COUNT : 91 REMARK 3 BIN FREE R VALUE : 0.2780 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 2102 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 62 REMARK 3 SOLVENT ATOMS : 311 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : 12.73 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : 0.00000 REMARK 3 B22 (A**2) : 0.00000 REMARK 3 B33 (A**2) : 0.00000 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : 0.00000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED OVERALL COORDINATE ERROR. REMARK 3 ESU BASED ON R VALUE (A): 0.117 REMARK 3 ESU BASED ON FREE R VALUE (A): 0.115 REMARK 3 ESU BASED ON MAXIMUM LIKELIHOOD (A): 0.068 REMARK 3 ESU FOR B VALUES BASED ON MAXIMUM LIKELIHOOD (A**2): 1.967 REMARK 3 REMARK 3 CORRELATION COEFFICIENTS. REMARK 3 CORRELATION COEFFICIENT FO-FC : 0.951 REMARK 3 CORRELATION COEFFICIENT FO-FC FREE : 0.918 REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES COUNT RMS WEIGHT REMARK 3 BOND LENGTHS REFINED ATOMS (A): 2247 ; 0.010 ; 0.020 REMARK 3 BOND LENGTHS OTHERS (A): NULL ; NULL ; NULL REMARK 3 BOND ANGLES REFINED ATOMS (DEGREES): 3067 ; 1.469 ; 1.998 REMARK 3 BOND ANGLES OTHERS (DEGREES): NULL ; NULL ; NULL REMARK 3 TORSION ANGLES, PERIOD 1 (DEGREES): 254 ; 5.185 ; 5.000 REMARK 3 TORSION ANGLES, PERIOD 2 (DEGREES): 109 ;37.061 ;25.963 REMARK 3 TORSION ANGLES, PERIOD 3 (DEGREES): 390 ;13.986 ;15.000 REMARK 3 TORSION ANGLES, PERIOD 4 (DEGREES): 6 ;10.882 ;15.000 REMARK 3 CHIRAL-CENTER RESTRAINTS (A**3): 318 ; 0.086 ; 0.200 REMARK 3 GENERAL PLANES REFINED ATOMS (A): 1756 ; 0.008 ; 0.022 REMARK 3 GENERAL PLANES OTHERS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED CONTACTS REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED CONTACTS OTHERS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED TORSION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED TORSION OTHERS (A): NULL ; NULL ; NULL REMARK 3 H-BOND (X...Y) REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 H-BOND (X...Y) OTHERS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY VDW REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY VDW OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY H-BOND REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY H-BOND OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 MAIN-CHAIN BOND REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 MAIN-CHAIN BOND OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 MAIN-CHAIN ANGLE REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 MAIN-CHAIN ANGLE OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN BOND REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN BOND OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 LONG RANGE B REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 LONG RANGE B OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 ANISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 RIGID-BOND RESTRAINTS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; FREE ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; BONDED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 NCS RESTRAINTS STATISTICS REMARK 3 NUMBER OF DIFFERENT NCS GROUPS : NULL REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : NULL REMARK 3 PARAMETERS FOR MASK CALCULATION REMARK 3 VDW PROBE RADIUS : 1.20 REMARK 3 ION PROBE RADIUS : 0.80 REMARK 3 SHRINKAGE RADIUS : 0.80 REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: HYDROGENS HAVE BEEN USED IF PRESENT IN REMARK 3 THE INPUT REMARK 4 REMARK 4 5VOM COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 10-MAY-17. REMARK 100 THE DEPOSITION ID IS D_1000227777. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 04-JUL-12 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 6.8 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : AUSTRALIAN SYNCHROTRON REMARK 200 BEAMLINE : MX2 REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.9537 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : ADSC QUANTUM 315R REMARK 200 INTENSITY-INTEGRATION SOFTWARE : XDS REMARK 200 DATA SCALING SOFTWARE : XDS REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 27843 REMARK 200 RESOLUTION RANGE HIGH (A) : 1.660 REMARK 200 RESOLUTION RANGE LOW (A) : 39.180 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 96.1 REMARK 200 DATA REDUNDANCY : 4.200 REMARK 200 R MERGE (I) : 0.08920 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 13.6000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 1.66 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 1.77 REMARK 200 COMPLETENESS FOR SHELL (%) : 90.7 REMARK 200 DATA REDUNDANCY IN SHELL : NULL REMARK 200 R MERGE FOR SHELL (I) : 0.38200 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : NULL REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: PHASER REMARK 200 STARTING MODEL: NULL REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 31.95 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 1.81 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 30% PEG 4000, 0.1 M MES PH 6.8, VAPOR REMARK 280 DIFFUSION, HANGING DROP, TEMPERATURE 291K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 1 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1, 2 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 2 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 MET A 20 REMARK 465 HIS A 21 REMARK 465 HIS A 22 REMARK 465 HIS A 23 REMARK 465 HIS A 24 REMARK 465 HIS A 25 REMARK 465 HIS A 26 REMARK 465 SER A 27 REMARK 465 SER A 28 REMARK 465 GLY A 29 REMARK 465 VAL A 30 REMARK 465 ASP A 31 REMARK 465 LEU A 32 REMARK 465 GLY A 33 REMARK 465 THR A 34 REMARK 465 GLU A 35 REMARK 465 ASN A 36 REMARK 465 LEU A 37 REMARK 465 TYR A 38 REMARK 465 PHE A 39 REMARK 465 GLN A 40 REMARK 465 SER A 41 REMARK 465 GLU A 168 REMARK 465 MET B 20 REMARK 465 HIS B 21 REMARK 465 HIS B 22 REMARK 465 HIS B 23 REMARK 465 HIS B 24 REMARK 465 HIS B 25 REMARK 465 HIS B 26 REMARK 465 SER B 27 REMARK 465 SER B 28 REMARK 465 GLY B 29 REMARK 465 VAL B 30 REMARK 465 ASP B 31 REMARK 465 LEU B 32 REMARK 465 GLY B 33 REMARK 465 THR B 34 REMARK 465 GLU B 35 REMARK 465 ASN B 36 REMARK 465 LEU B 37 REMARK 465 TYR B 38 REMARK 465 PHE B 39 REMARK 465 GLN B 40 REMARK 465 SER B 41 REMARK 465 GLU B 168 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS REMARK 500 REMARK 500 THE FOLLOWING ATOMS THAT ARE RELATED BY CRYSTALLOGRAPHIC REMARK 500 SYMMETRY ARE IN CLOSE CONTACT. AN ATOM LOCATED WITHIN 0.15 REMARK 500 ANGSTROMS OF A SYMMETRY RELATED ATOM IS ASSUMED TO BE ON A REMARK 500 SPECIAL POSITION AND IS, THEREFORE, LISTED IN REMARK 375 REMARK 500 INSTEAD OF REMARK 500. ATOMS WITH NON-BLANK ALTERNATE REMARK 500 LOCATION INDICATORS ARE NOT INCLUDED IN THE CALCULATIONS. REMARK 500 REMARK 500 DISTANCE CUTOFF: REMARK 500 2.2 ANGSTROMS FOR CONTACTS NOT INVOLVING HYDROGEN ATOMS REMARK 500 1.6 ANGSTROMS FOR CONTACTS INVOLVING HYDROGEN ATOMS REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI SSYMOP DISTANCE REMARK 500 O HOH B 393 O HOH B 429 1565 1.94 REMARK 500 O HOH A 323 O HOH A 416 1565 2.18 REMARK 500 REMARK 500 REMARK: NULL REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue 9GY A 201 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue 9GY B 201 DBREF 5VOM A 44 168 UNP O60885 BRD4_HUMAN 44 168 DBREF 5VOM B 44 168 UNP O60885 BRD4_HUMAN 44 168 SEQADV 5VOM MET A 20 UNP O60885 INITIATING METHIONINE SEQADV 5VOM HIS A 21 UNP O60885 EXPRESSION TAG SEQADV 5VOM HIS A 22 UNP O60885 EXPRESSION TAG SEQADV 5VOM HIS A 23 UNP O60885 EXPRESSION TAG SEQADV 5VOM HIS A 24 UNP O60885 EXPRESSION TAG SEQADV 5VOM HIS A 25 UNP O60885 EXPRESSION TAG SEQADV 5VOM HIS A 26 UNP O60885 EXPRESSION TAG SEQADV 5VOM SER A 27 UNP O60885 EXPRESSION TAG SEQADV 5VOM SER A 28 UNP O60885 EXPRESSION TAG SEQADV 5VOM GLY A 29 UNP O60885 EXPRESSION TAG SEQADV 5VOM VAL A 30 UNP O60885 EXPRESSION TAG SEQADV 5VOM ASP A 31 UNP O60885 EXPRESSION TAG SEQADV 5VOM LEU A 32 UNP O60885 EXPRESSION TAG SEQADV 5VOM GLY A 33 UNP O60885 EXPRESSION TAG SEQADV 5VOM THR A 34 UNP O60885 EXPRESSION TAG SEQADV 5VOM GLU A 35 UNP O60885 EXPRESSION TAG SEQADV 5VOM ASN A 36 UNP O60885 EXPRESSION TAG SEQADV 5VOM LEU A 37 UNP O60885 EXPRESSION TAG SEQADV 5VOM TYR A 38 UNP O60885 EXPRESSION TAG SEQADV 5VOM PHE A 39 UNP O60885 EXPRESSION TAG SEQADV 5VOM GLN A 40 UNP O60885 EXPRESSION TAG SEQADV 5VOM SER A 41 UNP O60885 EXPRESSION TAG SEQADV 5VOM ASN A 42 UNP O60885 EXPRESSION TAG SEQADV 5VOM ALA A 43 UNP O60885 EXPRESSION TAG SEQADV 5VOM MET B 20 UNP O60885 INITIATING METHIONINE SEQADV 5VOM HIS B 21 UNP O60885 EXPRESSION TAG SEQADV 5VOM HIS B 22 UNP O60885 EXPRESSION TAG SEQADV 5VOM HIS B 23 UNP O60885 EXPRESSION TAG SEQADV 5VOM HIS B 24 UNP O60885 EXPRESSION TAG SEQADV 5VOM HIS B 25 UNP O60885 EXPRESSION TAG SEQADV 5VOM HIS B 26 UNP O60885 EXPRESSION TAG SEQADV 5VOM SER B 27 UNP O60885 EXPRESSION TAG SEQADV 5VOM SER B 28 UNP O60885 EXPRESSION TAG SEQADV 5VOM GLY B 29 UNP O60885 EXPRESSION TAG SEQADV 5VOM VAL B 30 UNP O60885 EXPRESSION TAG SEQADV 5VOM ASP B 31 UNP O60885 EXPRESSION TAG SEQADV 5VOM LEU B 32 UNP O60885 EXPRESSION TAG SEQADV 5VOM GLY B 33 UNP O60885 EXPRESSION TAG SEQADV 5VOM THR B 34 UNP O60885 EXPRESSION TAG SEQADV 5VOM GLU B 35 UNP O60885 EXPRESSION TAG SEQADV 5VOM ASN B 36 UNP O60885 EXPRESSION TAG SEQADV 5VOM LEU B 37 UNP O60885 EXPRESSION TAG SEQADV 5VOM TYR B 38 UNP O60885 EXPRESSION TAG SEQADV 5VOM PHE B 39 UNP O60885 EXPRESSION TAG SEQADV 5VOM GLN B 40 UNP O60885 EXPRESSION TAG SEQADV 5VOM SER B 41 UNP O60885 EXPRESSION TAG SEQADV 5VOM ASN B 42 UNP O60885 EXPRESSION TAG SEQADV 5VOM ALA B 43 UNP O60885 EXPRESSION TAG SEQRES 1 A 149 MET HIS HIS HIS HIS HIS HIS SER SER GLY VAL ASP LEU SEQRES 2 A 149 GLY THR GLU ASN LEU TYR PHE GLN SER ASN ALA ASN PRO SEQRES 3 A 149 PRO PRO PRO GLU THR SER ASN PRO ASN LYS PRO LYS ARG SEQRES 4 A 149 GLN THR ASN GLN LEU GLN TYR LEU LEU ARG VAL VAL LEU SEQRES 5 A 149 LYS THR LEU TRP LYS HIS GLN PHE ALA TRP PRO PHE GLN SEQRES 6 A 149 GLN PRO VAL ASP ALA VAL LYS LEU ASN LEU PRO ASP TYR SEQRES 7 A 149 TYR LYS ILE ILE LYS THR PRO MET ASP MET GLY THR ILE SEQRES 8 A 149 LYS LYS ARG LEU GLU ASN ASN TYR TYR TRP ASN ALA GLN SEQRES 9 A 149 GLU CYS ILE GLN ASP PHE ASN THR MET PHE THR ASN CYS SEQRES 10 A 149 TYR ILE TYR ASN LYS PRO GLY ASP ASP ILE VAL LEU MET SEQRES 11 A 149 ALA GLU ALA LEU GLU LYS LEU PHE LEU GLN LYS ILE ASN SEQRES 12 A 149 GLU LEU PRO THR GLU GLU SEQRES 1 B 149 MET HIS HIS HIS HIS HIS HIS SER SER GLY VAL ASP LEU SEQRES 2 B 149 GLY THR GLU ASN LEU TYR PHE GLN SER ASN ALA ASN PRO SEQRES 3 B 149 PRO PRO PRO GLU THR SER ASN PRO ASN LYS PRO LYS ARG SEQRES 4 B 149 GLN THR ASN GLN LEU GLN TYR LEU LEU ARG VAL VAL LEU SEQRES 5 B 149 LYS THR LEU TRP LYS HIS GLN PHE ALA TRP PRO PHE GLN SEQRES 6 B 149 GLN PRO VAL ASP ALA VAL LYS LEU ASN LEU PRO ASP TYR SEQRES 7 B 149 TYR LYS ILE ILE LYS THR PRO MET ASP MET GLY THR ILE SEQRES 8 B 149 LYS LYS ARG LEU GLU ASN ASN TYR TYR TRP ASN ALA GLN SEQRES 9 B 149 GLU CYS ILE GLN ASP PHE ASN THR MET PHE THR ASN CYS SEQRES 10 B 149 TYR ILE TYR ASN LYS PRO GLY ASP ASP ILE VAL LEU MET SEQRES 11 B 149 ALA GLU ALA LEU GLU LYS LEU PHE LEU GLN LYS ILE ASN SEQRES 12 B 149 GLU LEU PRO THR GLU GLU HET 9GY A 201 31 HET 9GY B 201 31 HETNAM 9GY 3-[(2S)-1-ACETYL-4-(FURAN-2-CARBONYL)-2-METHYL-1,2,3,4- HETNAM 2 9GY TETRAHYDROQUINOXALIN-6-YL]-N-METHYLBENZAMIDE FORMUL 3 9GY 2(C24 H23 N3 O4) FORMUL 5 HOH *311(H2 O) HELIX 1 AA1 THR A 60 VAL A 69 1 10 HELIX 2 AA2 VAL A 69 HIS A 77 1 9 HELIX 3 AA3 ALA A 80 GLN A 84 5 5 HELIX 4 AA4 ASP A 96 ILE A 101 1 6 HELIX 5 AA5 ASP A 106 ASN A 116 1 11 HELIX 6 AA6 ASN A 121 ASN A 140 1 20 HELIX 7 AA7 ASP A 144 ASN A 162 1 19 HELIX 8 AA8 THR B 60 VAL B 69 1 10 HELIX 9 AA9 VAL B 69 LYS B 76 1 8 HELIX 10 AB1 ALA B 80 GLN B 84 5 5 HELIX 11 AB2 ASP B 96 ILE B 101 1 6 HELIX 12 AB3 ASP B 106 ASN B 116 1 11 HELIX 13 AB4 ASN B 121 ASN B 140 1 20 HELIX 14 AB5 ASP B 144 ASN B 162 1 19 SITE 1 AC1 13 TRP A 81 PRO A 82 GLN A 85 LEU A 92 SITE 2 AC1 13 LEU A 94 ASN A 140 ASP A 145 ILE A 146 SITE 3 AC1 13 HOH A 309 HOH A 321 HOH A 400 PHE B 79 SITE 4 AC1 13 LEU B 148 SITE 1 AC2 10 LYS A 155 TRP B 81 PRO B 82 LEU B 92 SITE 2 AC2 10 LEU B 94 TYR B 139 ASN B 140 ILE B 146 SITE 3 AC2 10 HOH B 329 HOH B 365 CRYST1 30.210 39.385 55.506 95.05 104.14 91.58 P 1 2 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.033102 0.000915 0.008467 0.00000 SCALE2 0.000000 0.025400 0.002493 0.00000 SCALE3 0.000000 0.000000 0.018668 0.00000